PMID: 8612190Jun 1, 1995Paper

Prognosis of epilepsy withdrawn from antiepileptic drugs

Psychiatry and Clinical Neurosciences
Y NakazawaH Motooka

Abstract

Antiepileptic drugs (AED) were discontinued in 55 epileptics who had been free from seizures treated with AED, in accordance with the following criteria and procedures. (i) A reduction in AED commences when patients have been free from seizures for at least 2 years and epileptic discharges have also disappeared in repeated electroencephalogram (EEG) recordings during that period. (ii) AED are gradually reduced if no relapse is seen in clinical seizures and epileptic discharges in EEG. (iii) As a rule at least 2 years are required as the interval from the onset of a reduction to the withdrawal of AED. Forty-three patients were followed up by a questionnaire and/or by telephone and the follow-up period from the withdrawal of AED to the survey ranged from 0.9 to 8.8 years; in 38 patients (88.4%) the period was longer than 2 years. No relapse of seizures was found in any of the 43 patients. The severity of epilepsy judged by the total number of frequency of seizures, the presence of neuropsychiatric complications, the combination of different types of seizures, and the duration of epilepsy from the seizure onset to the last seizure appeared not to be risk factors for the recurrence of seizure. Normal EEG was, however, considered to...Continue Reading

References

Dec 1, 1979·Epilepsia·J F AnnegersL R Elveback
Feb 16, 1991·BMJ : British Medical Journal·S D Shorvon
Apr 14, 1988·The New England Journal of Medicine·N CallaghanT Goggin
Apr 14, 1988·The New England Journal of Medicine·T A Pedley
Jan 1, 1988·Epilepsia·E H Reynolds
Dec 1, 1987·Journal of Neurology, Neurosurgery, and Psychiatry·P A BoumaJ Van Rossum
Nov 1, 1987·Epilepsy Research·J S Duncan, S D Shorvon
Jan 1, 1987·European Neurology·L Oller-Daurella, L Oller
Jul 1, 1986·Epilepsia·M G Marciani, J Gotman
Jun 22, 1985·British Medical Journal·D Chadwick, E H Reynolds
Jan 1, 1972·Epilepsia·E A Rodin
Jun 1, 1974·Epilepsia·J J Zieliński
Jan 1, 1972·Epilepsia·L Oller-Daurella, J Marquez
Jan 1, 1968·Acta Anatomica·W Lipp, M Rodin
May 10, 1980·British Medical Journal·J G Howe
Sep 3, 1983·British Medical Journal·D M Goodridge, S D Shorvon
Oct 11, 1984·The New England Journal of Medicine·R D ElwesE H Reynolds
Nov 1, 1984·Journal of Neurology, Neurosurgery, and Psychiatry·S D Shorvon
Nov 21, 1981·British Medical Journal·P G ClelandJ B Foster
May 7, 1981·The New England Journal of Medicine·R EmersonJ M Freeman
May 10, 1980·British Medical Journal·I N ScobieI R McNeil
Oct 18, 1952·Journal of the American Medical Association·M D YAHRH H MERRITT

❮ Previous
Next ❯

Citations

Dec 14, 2002·Mayo Clinic Proceedings·Jeffrey W Britton
Apr 24, 2019·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Juan YaoZheng Xiao

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.